HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.

Abstract
Clonidine has been suggested to be effective in Gilles de la Tourette's syndrome (GTS), but no double-blind study has ever evaluated its effects using objective measures. Thirty patients with GTS completed a 6-month placebo-controlled crossover study of the effectiveness of clonidine. Videotapes were obtained at each 3-week visit and were evaluated randomly at the end of the study for distribution, frequency, and severity of motor and vocal tics. Quantifiable psychometric examinations were performed as well. The use of clonidine did not significantly (p less than 0.05) reduce motor tics, vocalizations, or behavior. The effect of a low dose (0.0075 mg/kg/day) was no different from that of a high dose (0.015 mg/kg/day); children's responses were no different from adults'; and those also receiving neuroleptic agents showed the same lack of efficacy as seen in patients on no other medication. Dosing schedule did not affect the objective ratings; scores from clonidine given twice a day were equivalent to those for three times a day.
AuthorsC G Goetz, C M Tanner, R S Wilson, V S Carroll, P G Como, K M Shannon
JournalAnnals of neurology (Ann Neurol) Vol. 21 Issue 3 Pg. 307-10 (Mar 1987) ISSN: 0364-5134 [Print] UNITED STATES
PMID3300518 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Clonidine
Topics
  • Adolescent
  • Adult
  • Child
  • Clinical Trials as Topic
  • Clonidine (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Random Allocation
  • Tourette Syndrome (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: